← Back to Clinical Trials
Recruiting NCT06701006

NCT06701006 Integrated Suicide Supports and Safety Planning for Youth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06701006
Status Recruiting
Phase
Sponsor University of Washington
Condition Suicidal Ideation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-08-19
Primary Completion 2026-11-01

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 21 Years
Study Type INTERVENTIONAL
Interventions
Integrated skills and safety planning app

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-08-19 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate an app to help keep teens and young adults with suicidal thoughts safe. The app includes a safety plan created by adolescents and healthcare providers, and videos to encourage supportive communication and skills for teens and young adults to stay safe. The main question it aims to answer is whether the use of an app can increase youth suicide-related coping for youth with suicidal ideation, parent/caregiver suicide prevention self-efficacy, and healthcare provider self-efficacy in suicide management. Researchers will compare usual care to usual care with the app. Participants, including adolescents, caregivers, and healthcare providers, will use the ISSP app (if assigned to that group) and view video content and complete three online surveys.

Eligibility Criteria

Youth Inclusion Criteria: * Age 13 -21 years, an Ask Suicide Questions (ASQ) screen score of 1-5 with active ideation (not solely a history of a prior attempt) but no current plan or intent, or patient-reported suicidal thoughts and behaviors during a clinical assessment in a medical setting who are judged by a clinician to be appropriate for conducting higher level assessment in that setting (including a BSSA and/or safety planning) in order to support care at home. * Parents/guardians: One "parent" per AYA will also be invited to participate. * HCPs: All HCPs in participating settings who may conduct assessments of SI and safety planning (physicians, nurse practitioners/physician's assistants, social workers, mental health counselors, psychologists) will be invited to participate. * All subjects must have access to the internet and a computer or tablet device. Youth Exclusion Criteria: * Concurrently enrolled in an affiliated Suicide Care Research Center study, no phone access, or non-English speaking.

Contact & Investigator

Central Contact

Laura Richardson, MD, MPH

✉ lpr@uw.edu

📞 206-987-2028

Principal Investigator

Laura Richardson, MD, MPH

PRINCIPAL INVESTIGATOR

University of Washington

Frequently Asked Questions

Who can join the NCT06701006 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 21 Years, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06701006 currently recruiting?

Yes, NCT06701006 is actively recruiting participants. Contact the research team at lpr@uw.edu for enrollment information.

Where is the NCT06701006 trial being conducted?

This trial is being conducted at Seattle, United States.

Who is sponsoring the NCT06701006 clinical trial?

NCT06701006 is sponsored by University of Washington. The principal investigator is Laura Richardson, MD, MPH at University of Washington. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology